Article
LDCT combined with serum miR-4638-3p expression enhances NSCLC diagnostic efficacy and rs6601178 polymorphism susceptibility association.
Journal of cardiothoracic surgery - 21 May 2026
Meng Zeyu, Xue Ting, Jiang Bo
Abstract excerpt
BACKGROUND: Despite reducing lung cancer mortality, low-dose computed tomography (LDCT) is limited by a high false positive rate. This study integrates serum miR-4638-3p with LDCT to assess its diagnostic value in non-small cell lung cancer (NSCLC), explore miR-4638-3p's mechanisms, and analyze the rs6601178 polymorphism's association with NSCLC susceptibility. METHODS: Participants comprised 152 healthy controls...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
